Related references
Note: Only part of the references are listed.Machine Learning Uncovers Food- and Excipient-Drug Interactions
Daniel Reker et al.
CELL REPORTS (2020)
Onychomycosis Treatment and prevention of recurrence
Shari R. Lipner et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Inactive ingredients in oral medications
Daniel Reker et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Computational advances in combating colloidal aggregation in drug discovery
Daniel Reker et al.
NATURE CHEMISTRY (2019)
Hepatocellular Carcinoma
Augusto Villanueva
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Colloidal Drug Aggregate Stability in High Serum Conditions and Pharmacokinetic Consequence
Ahil N. Ganesh et al.
ACS CHEMICAL BIOLOGY (2019)
DrugBank 5.0: a major update to the DrugBank database for 2018
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2018)
Quantitative self-assembly prediction yields targeted nanomedicines
Yosi Shamay et al.
NATURE MATERIALS (2018)
Adversarial Controls for Scientific Machine Learning
Kangway V. Chuang et al.
ACS CHEMICAL BIOLOGY (2018)
Bile Acids and Their Derivatives as Potential Modifiers of Drug Release and Pharmacokinetic Profiles
Nebojsa Pavlovic et al.
FRONTIERS IN PHARMACOLOGY (2018)
Stable Colloidal Drug Aggregates Catch and Release Active Enzymes
Christopher K. McLaughlin et al.
ACS CHEMICAL BIOLOGY (2016)
Serum protein biomarkers relevant to hepatocellular carcinoma and their detection
Eric Waidely et al.
ANALYST (2016)
Multi-objective active machine learning rapidly improves structure-activity models and reveals new protein-protein interaction inhibitors
D. Reker et al.
CHEMICAL SCIENCE (2016)
An Aggregation Advisor for Ligand Discovery
John J. Irwin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
PERSPECTIVE Special delivery for the gut
Giovanni Traverso et al.
NATURE (2015)
Meloxicam combined with sorafenib synergistically inhibits tumor growth of human hepatocellular carcinoma cells via ER stress-related apoptosis
Jingtao Zhong et al.
ONCOLOGY REPORTS (2015)
The role of ligand efficiency metrics in drug discovery
Andrew L. Hopkins et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Nanoparticle-formulated siRNA targeting integrins inhibits hepatocellular carcinoma progression in mice
Roman L. Bogorad et al.
NATURE COMMUNICATIONS (2014)
Antiretroviral Solid Drug Nanoparticles with Enhanced Oral Bioavailability: Production, Characterization, and In Vitro-In Vivo Correlation
Tom O. McDonald et al.
ADVANCED HEALTHCARE MATERIALS (2014)
Colloidal Aggregation Affects the Efficacy of Anticancer Drugs in Cell Culture
Shawn C. Owen et al.
ACS CHEMICAL BIOLOGY (2012)
Aggregating Behavior of Phenolic Compounds - A Source of False Bioassay Results?
Leena Pohjala et al.
MOLECULES (2012)
NANOMEDICINE Downsizing tumour therapeutics
Christopher J. Cheng et al.
NATURE NANOTECHNOLOGY (2012)
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
H. Cabral et al.
NATURE NANOTECHNOLOGY (2011)
Multistage nanoparticle delivery system for deep penetration into tumor tissue
Cliff Wong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Sorafenib is active on lung metastases from synovial sarcoma
U. Basso et al.
ANNALS OF ONCOLOGY (2009)
Candidal onychomycosis: A Mini-Review
J. A. M. S. Jayatilake et al.
MYCOPATHOLOGIA (2009)
Towards a definition of inorganic nanoparticles from an environmental, health and safety perspective
Melanie Auffan et al.
NATURE NANOTECHNOLOGY (2009)
Review article: pharmacological therapy for hepatocellular carcinoma with sorafenib and other oral agents
M. Chaparro et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery
Aihua Lin et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Protective mechanism of glycyrrhizin on acute liver injury induced by carbon tetrachloride in mice
Chan-Ho Lee et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2007)
Distinct pathways of genomic progression to benign and malignant tumors of the liver
Aaron D. Tward et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Risk and safety assessment on the consumption of Licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin
R. A. Isbrucker et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2006)
Drug nanoparticles by antisolvent precipitation: Mixing energy versus surfactant stabilization
Michal E. Matteucci et al.
LANGMUIR (2006)
Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines
Jeongwu Lee et al.
CANCER CELL (2006)
Model organisms - The mighty mouse: genetically engineered mouse models in cancer drug development
Norman E. Sharpless et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
High-throughput assays for promiscuous inhibitors
BY Feng et al.
NATURE CHEMICAL BIOLOGY (2005)
The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs
JE Kipp
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)
Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation
H Gelderblom et al.
EUROPEAN JOURNAL OF CANCER (2001)
Share Paper
